|
Neonatal Intensive Care Drug Manual
|
bet | 54/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
Administration
|
IV infusion: over 30 to 40 minutes. [4],
Oral: Administer at the start of a feed (to increase absorption and decrease stomach upset); administer, around-the-clock to promote less variation in peak and trough serum levels. Shake suspension well, before measuring the dose. The dose may be mixed with milk. After mixing, administer immediately.
|
Monitoring
|
Renal and hepatic function, full blood count if on prolonged therapy.
|
Contraindications
|
Hypersensitivity to penicillins, cephalosporins and carbapenems. Previous history of jaundice/hepatic dysfunction associated with the combination or amoxicillin or, clavulanic acid. Severe renal impairment (creatinine clearance less than 30 mL/minute).
Note: infants <7 days, very preterm infants and sick infants frequently have a creatinine clearance <30, mL/minute.
|
Precautions
|
In moderate renal impairment: increase the dosing interval and maintain adequate fluid intake, especially with IV doses, to reduce the possibility of amoxicillin crystalluria.
Hepatic dysfunction: monitor liver function tests. Concurrent use in CMV infection increases risk of rash.
Oral suspension - contains aspartame (source of phenylketonuria), therefore use with caution in, patients with phenylketonuria.
|
7> |
|
| |